Search
Advanced Search
Help
|
Site Index
|
Contact Us
NIAID
>
Research
>
Research Resources
>
DMID Services for Researchers
>
In Vitro Antiviral Screening Program
Research
Research by Topic
Research Resources
Clinical Research Toolkit
DAIDS Clinical Research Policies
DMID Clinical Research Policies
DMID Services for Researchers
HIV/AIDS Specimen Repository
Rabbit Immunology
Services for Researchers
In Vitro Antiviral Screening Program
Prioritization and Approval Process
Materials for testing are selected and prioritized by relevant program officers from the Division of Microbiology and Infectious Diseases (DMID). Submitted compounds will be evaluated based on criteria such as structural novelty and drug-like characteristics as well as the rationale for submission, program priorities, and budgeted capacities in the antiviral screens requested. Final decisions are communicated to the submitter by the NIAID Project Officer.
Contact Info
Christopher Tseng
DMID Program Officer
E-mail:
ctseng@niaid.nih.gov
Search in Research
E-mail this page
Print this page
Contact Info
Christopher Tseng
DMID Program Officer
E-mail:
ctseng@niaid.nih.gov
Home
|
Help
|
Site Index
|
Accessibility
|
Privacy Policy
|
Disclaimer
|
Links & Policies
|
FOIA
|
Contact Us
Last Updated July 2, 2008
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health (NIH)
Department of Health and Human Services (HHS)